Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells.
Bergonzini C, Gregori A, Hagens TMS, van der Noord VE, van de Water B, Zweemer AJM, Coban B, Capula M, Mantini G, Botto A, Finamore F, Garajova I, McDonnell LA, Schmidt T, Giovannetti E, Danen EHJ. Bergonzini C, et al. Among authors: gregori a. J Exp Clin Cancer Res. 2024 Jan 2;43(1):4. doi: 10.1186/s13046-023-02879-8. J Exp Clin Cancer Res. 2024. PMID: 38163893 Free PMC article.
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC).
Gregori A, Bergonzini C, Capula M, Mantini G, Khojasteh-Leylakoohi F, Comandatore A, Khalili-Tanha G, Khooei A, Morelli L, Avan A, Danen EH, Schmidt T, Giovannetti E. Gregori A, et al. Cancers (Basel). 2023 Jan 19;15(3):628. doi: 10.3390/cancers15030628. Cancers (Basel). 2023. PMID: 36765586 Free PMC article.
Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells.
Che PP, Gregori A, Bergonzini C, Ali M, Mantini G, Schmidt T, Finamore F, Rodrigues SMF, Frampton AE, McDonnell LA, Danen EH, Slotman BJ, Sminia P, Giovannetti E. Che PP, et al. Among authors: gregori a. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1328-1343. doi: 10.1016/j.ijrobp.2023.10.035. Epub 2023 Oct 31. Int J Radiat Oncol Biol Phys. 2024. PMID: 37914140
"Open Sesame?": Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer.
Randazzo O, Papini F, Mantini G, Gregori A, Parrino B, Liu DSK, Cascioferro S, Carbone D, Peters GJ, Frampton AE, Garajova I, Giovannetti E. Randazzo O, et al. Among authors: gregori a. Cancers (Basel). 2020 Oct 31;12(11):3206. doi: 10.3390/cancers12113206. Cancers (Basel). 2020. PMID: 33142664 Free PMC article.
A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?
Leonetti A, Carbone D, Gregori A, Tiseo M, Peters GJ, Deng D, Giovannetti E. Leonetti A, et al. Among authors: gregori a. J Cancer Res Clin Oncol. 2021 Oct;147(10):3135-3137. doi: 10.1007/s00432-021-03647-x. Epub 2021 Apr 26. J Cancer Res Clin Oncol. 2021. PMID: 33900435 No abstract available.
180 results